Neurodegenerative diseases refer to a group of progressive conditions that cause the neurons in the brain and spinal cord to deteriorate over time. These diseases not only cause physical and cognitive impairments but also lead to significant emotional stress and an overall decline in quality of life. Over the last few years, genetics has been pinpointed as an obvious factor in the pathogenesis of these diseases. The discovery of genetic links to neurodegenerative disorders has led to an increased focus on the role of genetic risk factors in disease susceptibility. Genetic mutations, deletions, and alterations have been identified for many neurodegenerative diseases, such as Huntington’s disease, Alzheimer’s disease, and Parkinson’s disease. For instance, the Huntington’s disease-causing CAG repeat mutation is located in the Huntington’s gene. This gene codes for the enzyme Huntingtin, which is found in large concentrations in the brain and implicated in the disease pathogenesis. Parkinson’s disease is linked to several mutations on at least four genes. The most important of these is the LRRK2 gene, which carries a greater risk of developing Parkinson’s compared to other genes. For Alzheimer’s disease, a mutation in the ApoE gene has been found to increase the risk of developing the disease. Furthermore, other genes implicated in the disease's risk include APP, PSEN1, and PSEN2. With the advancements in genetic research and testing, doctors and scientists may be able to develop preventive strategies, appropriate treatments, and even cures for neurodegenerative disorders. The insight gained from genetic studies can help researchers design targeted therapies, unravel pathways involved in the pathogenesis of such diseases, and help patients make informed decisions regarding their health. At the same time, genetic testing for neurodegenerative diseases does come with certain risks, such as having to cope with an unexpected diagnosis, stigma, and anxiety. Thus, genetic testing should only be conducted after taking into consideration the emotional and physical impact it may have on an individual.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States